Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.16732 | 47 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.26386 | 52 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.17331 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.08396 | 48 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.26449 | 53 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.1978 | 47 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.15871 | 46 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.93235 | 41 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.15543 | 49 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.36215 | 55 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.15493 | 49 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.16015 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.1327 | 48 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.27942 | 53 |